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ABSTRACT 
Metabolic gas analysis is a critical component of investigations that measure cardio-pulmonary 
exercise responses during and after long-duration spaceflight.  The primary purpose of the current study 
was to determine the reliability and intra-subject repeatability of a metabolic gas analysis device, the 
Portable Pulmonary Function System (PPFS), designed for use on the International Space Station (ISS).  
The second objective of this study was to directly compare PPFS measurements of fractions of expired 
oxygen and carbon dioxide (FEO2 and FECO2) to values obtained from a well-validated clinical 
metabolic gas analysis system (ParvoMedics TrueOne© [PM]).  METHODS: Eight subjects performed 
four peak cycle tests to maximal exertion.  The first test was used to prescribe work rates for the 
subsequent test sessions.  Metabolic gas analysis for this test was performed by the PM, but samples of 
FEO2 and FECO2 also were simultaneously collected for analysis by  the PPFS.  Subjects then 
performed three additional peak cycle tests, consisting of three 5-min stages designed to elicit 25%, 
50%, and 75% maximal oxygen consumption (VO2max) followed by stepwise increases of 25 W/min 
until subjects reached volitional exhaustion.  Metabolic gas analysis was performed using the PPFS for 
these tests.  Intraclass correlation coefficients (ICC), within-subject standard deviations (WS SD), and 
coefficients of variation (CV%) were calculated for the repeated exercise tests.  Mixed model regression 
analysis was used to compare paired FEO2 and FECO2 values obtained from the PPFS and the PM 
during the initial test.  RESULTS: The ICC values for oxygen consumption (VO2), carbon dioxide 
production (VCO2), and ventilation (VE) indicate that the PPFS is highly reliable (0.79 to 0.99) for all 
exercise levels tested; however, ICCs for respiratory exchange ratio (RER) were low (0.11 – 0.51), 
indicating poor agreement between trials during submaximal and maximal exercise.  Overall, CVs 
ranged from 1.6% to 6.7% for all measurements, a finding consistent with reported values that were 
obtained using other metabolic gas analysis techniques.  The PPFS and PM produced comparable FEO2 
data; however, there was less agreement between measures of FECO2 obtained from the two devices, 
particularly at lower CO2 concentrations.  CONCLUSIONS: The PPFS appears, in practically all 
respects, to yield highly reliable metabolic gas analysis data.  Lower reliability of RER measurements 
reported in the literature and likely is not a function of the PPFS device.  Further examination of PPFS 
CO2 data is warranted to better understand the limitations of these PPFS measurements.  Overall, the 
PPFS when used for repeated measures of cardio-pulmonary exercise should provide accurate and 
reliable data for studies of human adaptation to spaceflight. 
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INTRODUCTION 
 As specified in the National Aeronautics and Space Administration (NASA) Human Research 
Program’s Integrated Research Plan (NASA HRP 47065, 2010), acquisition of data regarding maximal 
oxygen consumption (VO2max) during and after spaceflight is a high priority to support future space 
exploration endeavors.  A metabolic gas analysis system capable of being used in spacecraft is required 
to support this requirement.  One such device, known as the Pulmonary Function System (PFS), was 
developed for International Space Station (ISS) use and was validated in the Exercise Physiology 
Laboratory at NASA Johnson Space Center (15).  The PFS has been used to support studies of resting 
metabolism and cardiac function on board ISS, but this device is not portable and is confined to a 
relatively immobile rack location.  The exercise equipment onboard ISS has changed locations since 
earlier expeditions, and the cycle ergometer used for exercise testing was moved to a different module 
than the one containing the PFS.  Thus, the need for a portable metabolic gas analysis device for ISS 
use arose.  The Portable Pulmonary Function System (PPFS) was developed by a contractor to the 
European Space Agency, Damec Research Aps (currently named Danish Aerospace Corporation, 
[DAC]).  The PPFS is a smaller version of the PFS that can be used on board the ISS in any location 
that has power and data connections. 
A NASA-sponsored validation study of the PPFS was conducted in 2009, before it was 
delivered to the ISS (17).  The metabolic gas analysis values from the PPFS were comparable to values 
obtained from a well-validated reference system ParvoMedics TrueOne© (PM) (2, 6, 7), and any 
statistically significant differences that did occur were not clinically relevant.  However, the 
reproducibility of the PPFS measurements were not examined in the 2009 study, and results suggested 
that PPFS measurements of expired carbon dioxide (FECO2) may differ from FECO2 values measured 
by the reference system.  The hardware design precluded measuring expired oxygen (FEO2) or FECO2 
from both devices simultaneously, and further investigation was warranted. 
The primary purpose of the current study was to examine the reliability and intra-subject 
repeatability of metabolic gas analysis data obtained from the PPFS during exercise tests that included 
both steady-state submaximal stages and maximal exertion levels.  The secondary purpose was to 
collect FEO2 and FECO2 data simultaneously in a manner that would allow direct comparison of the 
data obtained from the PPFS and the data from the PM. 
METHODS 
Subjects 
Eight healthy subjects (Table 1) volunteered to participate in this study.  Subjects passed a 
modified Air Force Class III physical exam before they participated and received written and verbal 
explanations of test protocols before providing written informed consent.  The NASA Johnson Space 
Center Committee for the Protection of Human Subjects reviewed and approved the test protocols and 
procedures. 
Table 1.  Subject Characteristics (mean ± SD).  Reported VO2max values were measured in the 
initial peak cycle test. 
 Male (n=5) Female (n=3) 
Age (yr) 37.4 ± 11.5 29.7 ± 2.5 
Weight (kg) 86.9 ± 11.2 54.4 ± 2.9 
Height (cm) 179.8 ± 7.0 161.7 ± 5.3 
VO2max (ml/kg/min) 39.6 ± 4.6 40.8 ± 9.7 
The cycle ergometer used for all testing was a LODE Excalibur Sport (Groningen, NL).  The 
subjects fasted overnight before the testing sessions and consumed a standardized dietary supplement 
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(Ensure®, Abbott Laboratories) about 2 hours before testing.  Dietary extremes affect metabolic gas 
analysis results (24), so the dietary control ensured that none of the subjects consumed either an 
extremely high-fat or high-carbohydrate meal before their tests.  Tests were performed between 08:30 
a.m. and 10:00 a.m., with one exception; scheduling constraints compelled one subject to perform a 
trial in the afternoon, 2 hours after consuming Ensure®.  The subject ate a light breakfast early that 
morning but otherwise followed the constraints of the study.  None of the subjects performed heavy 
exercise during the 24 hours before the testing sessions.  Subjects also refrained from caffeine 
consumption for 12 hours prior to testing. 
Peak Cycle Tests 
Subjects performed an initial peak cycle test using the same protocol that astronauts performed 
to measure VO2max before an ISS mission (20, 21).  Subjects with a body mass of > 65 kg cycled for 
three minutes at 50, 100, and 150 watts (W) followed by stepwise increases of 25 W/min until peak 
exertion was reached.  Subjects with body mass < 65 kg cycled for three minutes at 50, 75, and 100 W, 
followed by stepwise increases of 25 W/min until peak exertion was attained.  The test was terminated 
by the subject at volitional exhaustion (i.e., the subject indicated that they could no longer continue) or 
the subject could not maintain a pedal cadence at or near 75 revolutions per minute.  During this initial 
test, the PM system was used to analyze expired metabolic gases.  VO2 and work rate data from the 
first test was used to prescribe the protocol for PPFS reliability tests. 
Each subject performed three additional peak cycle tests to obtain data from the PPFS to assess 
its reproducibility.  This cycle exercise testing protocol, identical to that used for an ISS exercise study 
(16), consisted of three 5-minute stages designed to elicit 25%, 50%, and 75% of the individual’s 
previously determined VO2max (from the initial peak cycle test).  These stages were followed by 
stepwise increases of 25 W/min work rate until subjects reached volitional exhaustion.  The first of 
these repeatability trials was conducted within a month of the initial test, with subsequent trials 
separated from each other by at least a week to minimize the potential effects of residual soreness or 
fatigue.  No more than three weeks elapsed between any two trials.  Subjects were instructed to not 
substantially vary their physical activities between trials. 
For all repeatability trials, prior to the start of exercise subjects rested quietly for five minutes 
in the seated position on the ergometer while resting heart rate (HR) and blood pressure (BP) were 
measured.  HR and heart rhythm were measured electrocardiographically using the PPFS, which has an 
internal electrocardiogram (ECG) recording system.  Volumes of expired gases along with HR were 
measured continuously throughout the exercise test protocol. 
Metabolic Gas Analysis Systems 
The PM system uses a paramagnetic oxygen analyzer (operating range 0%-25% O2) and an 
infrared single-beam, single-wavelength carbon dioxide analyzer (operating range 0%-15% CO2) to 
measure the composition of expired gases.  The subject inspires through a two-way non-rebreathing 
valve (Hans Rudolph Model 2700, Kansas City, MO), and expired air composition is analyzed in a 4-
liter mixing chamber.  The inspired gas composition was assumed to be standard atmospheric values 
(i.e., 20.93% O2 and 0.03% CO2).  Expired ventilation is measured using a Hans Rudolph Model 3813 
linear pneumotach (operating flow range 0-800 L/min).  Computational software is provided with the 
system.  In the initial test, data were collected continuously by the PM system and were averaged in 
30-second intervals to the nearest whole breath.  For purposes of this study, the accepted value of 
VO2max was taken as the highest VO2 attained for a 60-second period (average of two consecutive 30-
second values), which for all tests corresponded to the final minute of exercise. 
The PPFS uses two types of technology for gas analysis.  A photoacoustic method of gas 
analysis is used to measure CO2 concentration.  In this technique, the gas sample is exposed to 
intermittent infrared light.  The gas sample absorbs the light, and the heat from the absorbed energy 
results in an increase in pressure in the sample chamber.  The intermittent infrared light is divided into 
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different pulsation frequencies and is filtered optically.  Each optical filter allows only specific 
wavelengths of light to pass through.  The wavelengths correspond to the infrared absorption spectra of 
the sample gases.  When the light source is removed the gas cools down, resulting in a pressure 
fluctuation.  Because the pulsation frequency is in the audible range, the pressure fluctuation becomes 
an acoustic signal that is detected by a microphone.  The sounds recorded by the microphone are 
analyzed and the amplitude of each signal is used to calculate the gas concentration.  The PPFS 
operating range for CO2 concentration is from 0% to12%.  An Oxigraf™ sensor in the PPFS is used for 
O2 analysis.  The Oxigraf™ uses a spectroscopy technique for laser diode absorption in which the 
sample gas is exposed to a laser with a wavelength of 760 nm (the peak of oxygen absorption).  The 
laser signal is attenuated in proportion to the concentration of O2 present in the sample.  The PPFS 
operating range for O2 concentration is from 0% to 100%.  When using the PPFS during exercise 
testing, the subject inspires through a DAC custom-designed two-way non-rebreathing valve and the 
expired gases are sampled in a 15-liter anesthesia bag that serves as a mixing reservoir.  Ventilation is 
measured on the inspired side of the non-rebreathing valve using a DAC custom-designed pneumotach 
(operating flow range 0-900 L/min).  The technologies used for PPFS metabolic gas analysis are 
further described by Clemensen and colleagues (6).  A proprietary software package developed by 
DAC, named ADAM, was used to compute metabolic gas analysis variables. 
Expired Gas Sampling Comparisons 
During the initial peak cycle test, fractions of expired oxygen (FEO2) and expired carbon 
dioxide (FECO2) were sampled concurrently by PPFS and the PM.  The distal end of the PPFS gas 
sampling capillary tube was affixed adjacent to the gas sampling port of the PM (internal to the PM 
mixing chamber).  Data collection from both devices was started at the same time under room-air 
conditions.  Subjects breathed into the mixing chamber at seated rest for two minutes prior to the start 
of exercise.  Following the exercise test, both the PM and the PPFS gas sample capillary tubes were 
extracted from the mixing chamber simultaneously.  This produced a step function in the FEO2 and 
FECO2 data from each device, allowing precise synchronization of the two data streams.  For statistical 
comparisons, data from each device were expressed as 30-second averages.  A total of 217 paired 
FEO2 and FECO2 observations were obtained using this method. 
STATISTICAL METHODS 
The repeatability of maximal and sub-maximal gas-exchange data was assessed from the results 
of the three duplicate trials with the PPFS.  Maximal values were derived for each outcome by 
averaging the final 60 seconds of exercise test data.  These values were then analyzed using one-way 
ANOVA to estimate the within-subject standard deviation (WS SD) and the intra-class correlation 
coefficients (ICC).  The within-subjects coefficients of variation (CV %) was calculated as the ratio of 
the WS SD to the mean value over all subjects expressed as a percentage.  Outcome measures 
evaluated were: VO2max (both L/min and ml/kg/min), maximum volume of carbon dioxide produced 
(VCO2max, L/min), maximal respiratory exchange ratio (RERmax), maximal ventilation (VE, L/min), 
maximal heart rate (HRmax, beats/min), oxygen pulse (ml/beat) and maximal watts obtained.  
Maximal watts were estimated by linear interpolation between the highest work rates in the last two 
30-second intervals, and values were calculated based on time spent at the highest workload as a 
fraction of one minute. For example, if a subject terminated a test at 24 sec between 300W and 325W, 
the maximal watt value was recorded as 310W = 300W + (24/60) x 325W.  A similar ANOVA model 
was used to assess repeatability in terms of WS SD, ICC, and CV% for the same outcome measures at 
each of the 25%, 50%, and 75% VO2max sub-maximal exercise stages. 
Paired values of FEO2 and FECO2 obtained from the PM and PPFS during the initial peak cycle 
test were compared with a mixed-model regression analysis that modeled each PPFS measurement as 
β0 + β1 times the corresponding PF measurement + random error.  The random error component of the 
model allowed for differences between subjects in both slope (β1) and intercept (β0).  After fitting the 
-
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model, 95% confidence limits for β0 and β1 were obtained, and we also tested the joint null hypothesis 
that β1  = 1 and β0 = 0 (a perfect match). 
RESULTS 
Maximal Exercise 
Table 2 contains the ICC, WS SD, and mean CV% values of the PPFS measurements at 
maximal exercise.  Of these, the ICC values demonstrated very strong intra-subject reliability, with the 
notable exception of RER (ICC = 0.51).  The CV for all variables were less than 6%.  The individual 
and the mean values obtained at maximum exercise are shown in Figure 1.  As shown in panel D, the 
RER values for two subjects were not stable, varying by as much as 0.16 from trial to trial.  One of 
these subjects was the individual who performed the afternoon trial. 
Table 2.  Intraclass Correlation Coefficients (ICC), Within-Subject Standard Deviations (WS 
SD), and Coefficients of Variation (CV%) at Maximal Exertion. 
Variable ICC WS SD CV(%) 
VO2max (L/min) 0.98 0.11 3.6 
VO2max (ml/kg/min) 0.92 1.91 4.6 
VCO2max (L/min) 0.94 0.18 5.4 
RERmax 0.51 0.05 4.0 
VEmax (L/min) 0.94 6.34 5.6 
HRmax 0.96 2.96 1.6 
Oxygen Pulse (ml/beat) 0.98 0.53 3.1 
Watts max 0.96 10.32 3.7 
For this report the following convention was used when interpreting the ICC data: 0-0.2 
indicates poor reliability, 0.3-0.4 indicates fair reliability, 0.5-0.6 indicates moderate reliability, 0.7-
0.8 indicates strong reliability, and >0.8 indicates very strong reliability.  (Adapted from: 
http://www.stattools.net/ICC_Exp.php#Interpretation%20of%20results) 
 11 
 
Figure 1.  Metabolic gas analysis, HR, and work rate (watts) data measured at maximal 
exertion during three trials (I, II, III).  The mean values are shown as dark circles connected by heavy, 
solid lines.  Smaller, open symbols connected by thin lines represent the data from individual subjects. 
Submaximal Exercise 
Table 3 displays the ICC, WS SD, and mean CV% values of the dependent variables measured 
during the 25%, 50%, and 75% of VO2max levels of exercise.  As was the case for the maximal 
exercise values, the ICC data indicated strong to very strong intra-subject reliability for the variables 
studied with the exception of RER (ICC range 0.11 – 0.31).  The mean CV did not exceed 7% for any 
combination of variables and in most cases was much lower than 7%.  The individual and mean values 
for each level of exercise (Figures 2-4) appeared to be very reproducible, with the notable exception of 
the RER values (Figure 3). 
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Table 3.  Intra-class Correlation Coefficients (ICC), Within-Subject Standard Deviations (WS 
SD), and Coefficients of Variation (CV%) during Submaximal Exercise 
 25% VO2max 50% VO2max 75% VO2max 
Variable ICC WS 
SD 
CV 
(%) 
ICC WS 
SD 
CV 
(%) 
ICC WS 
SD 
CV 
(%) 
VO2 (L/min) 0.90 0.05 4.9 0.95 0.07 4.4 0.99 0.06 2.6 
VCO2 (L/min) 0.79 0.06 6.7 0.90 0.09 5.6 0.97 0.11 4.4 
RER 0.31 0.04 4.4 0.11 0.04 4.0 0.24 0.03 3.2 
VE (L/min) 0.83 1.71 5.7 0.84 3.13 6.6 0.96 3.42 4.5 
HR 
(beats/min) 0.93 5.07 5.2 0.87 5.92 4.7 0.93 4.16 2.7 
Oxygen Pulse 
(ml/beat) 0.93 0.69 6.5 0.97 0.544 4.1 0.98 0.48 3.2 
For this report the following convention was used when interpreting the ICC Data: 0-0.2 
indicates poor reliability, 0.3-0.4 indicates fair reliability, 0.5-0.6 indicates moderate reliability, 0.7-
0.8 indicates strong reliability, and >0.8 indicates very strong reliability.  (Adapted from: 
http://www.stattools.net/ICC_Exp.php#Interpretation%20of%20results) 
 
Figure 2.  VO2 and VCO2 during submaximal exercise across the three trials (I, II, III).  The 
mean values are shown as dark circles connected by heavy, solid lines.  Smaller, open symbols 
connected by thin lines represent the data from individual subjects. 
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Figure 3.  RER and VE submaximal exercise data across the three trials (I, II, III).  The mean 
values are shown as dark circles connected by heavy, solid lines.  Smaller, open symbols connected by 
thin lines represent the data from individual subjects. 
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Figure 4.  HR and oxygen pulse submaximal exercise data across the three trials (I, II, III).  
The mean values are shown as dark circles connected by heavy, solid lines.  Smaller, open symbols 
connected by thin lines represent the data from individual subjects. 
FEO2 and FECO2 
Figure 5 shows the FEO2 and FECO2 values that were measured simultaneously using the 
PPFS and the PM systems.  The FEO2 data from the two devices were comparable.  The estimated 
linear equation expressing the relationship between the devices was PPFS FEO2= (0.982*PM FEO2) + 
0.265 (?̂?𝛽1 = 0.982, ?̂?𝛽0 = 0.265).  The values β ̂1 and β ̂2 were not significantly different from 1.0 and 0, 
respectively (P = 0.55, joint test).  The FECO2 data collected from each of the devices also matched 
fairly well, but not as closely as the FEO2 data; the estimated relationship was PPFS FECO2= 
(0.921*PM FEO2) + 0.390 (?̂?𝛽1 = 0.923, ?̂?𝛽0 = 0.390).  While there was not enough evidence (p = 0.11, 
joint test) to show a significant departure from the optimal values β1 = 1 and β0 = 0, the 95% 
confidence interval for β1 (0.84, 1.00) indicated a probable reduced gain (β1 < 1) in PPFS output 
relative to changes in PF measurements (Fig. 5B). 
25% VO2max
H
R
 (b
ea
ts
/m
in
)
60
80
100
120
140
160
180
200
I II III
O
xy
ge
n 
Pu
ls
e 
(m
l/m
in
)
4
8
12
16
20
24
50% VO2max
Trial
I II III
75% VO2max
I II III
~ 
~ 
• • • ~ 
 15 
 
Figure 5.  The FEO2 (left panel) measured by the two devices were comparable; the slope of 
the line describing their relationship did not differ from 1.0 and its intercept did not differ from 0.  The 
FECO2 (right panel) measured by two devices also were highly related.  However, for FECO2, the 
slope of the line describing the relation between the measurements from the two devices was slightly 
less than 1.0.  Future investigators may consider using a calibration factor when using the PPFS 
FECO2 values for metabolic calculations. 
DISCUSSION 
The primary finding of this study is that gas analysis measurements obtained with the PPFS 
were very repeatable, with the exception of the RER (see below).  The secondary finding of this study 
was that while FEO2 values from the PPFS and PM were strongly correlated, values of FECO2 
obtained with the PPFS tended to be lower than corresponding values observed with the PM. 
Maximal Exercise 
The mean values for PPFS-measured VO2, VCO2, VE, RER, HR, and watts at maximal exercise 
were consistent across the three repeatability trials (Figure 1).  The intra-class correlation coefficients 
indicated very strong reliability (i.e., agreement between the trials for each subject) for all outcome 
variables studied, with the exception of RER, which only moderate repeatability (ICC = 0.51, Table 
2).  These findings are similar to ICC values reported from repeated exercise trials in other studies.  
For example, in a study reporting reliability of physiological measurements of walking economy, the 
ICCs of VO2, VE, HR and RER were 0.92, 0.92, 0.90, and 0.31, respectively (25).  The vast majority of 
studies on the reliability of gas exchange measurements do not report ICC values of RER data.  
Because RER is a ratio derived from two other gas exchange measurements (RER = VCO2/VO2), it is 
likely that investigators consider reporting it to be redundant and unnecessary.  However, as shown in 
the current study, the RER response to exercise can be quite variable even if the measurements of VO2 
and VCO2 are highly reliable.  The RER during exercise can be influenced by a number of factors, 
including pre-exercise diet, muscle fiber type, muscle glycogen content, lactate metabolism, and 
training volume (8).  Although our subjects’ diet was controlled before the tests and subjects refrained 
from heavy exercise the day before their tests, it is obvious that these restrictions did not completely 
remove variation in the RER response to exercise. 
The CVs estimated from our subjects’ maximal data agree with values reported in the literature 
for VO2max (Table 4).  For the outcome variables we studied, CV values ranged from 1.6% to 5.6% 
and in particular, the CV for VO2 observed in this study (3.6%) agrees strongly with those reported 
from the multiple studies in Table 4.  The implication is that a VO2max variation of ± 3.6% with the 
PPFS is about as good as one could expect, even from ground-based hardware.  If changes in VO2max 
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are greater than 3.6%, it is highly likely that VO2max is being influenced by factors such as 
deconditioning, improvement in aerobic fitness, or motivation to perform the test.  Mean VO2max is 
reduced by approximately 20% compared to pre-flight after short-duration missions (~2 weeks) (14, 
18), and VO2max decreased by about 15% after long-duration missions (>90 days) (16).  These 
changes in VO2max that are well within the detection range for the PPFS. 
Table 4.  Summary of previous studies and their reported CV for VO2.  The higher values 
reported are from evaluations of metabolic gas analysis systems that produce less consistent results. 
Citation Measure CV (%) 
Armstrong and Costill (1) Submaximal VO2 4.4 
Brawner et al. (3) VO2max 5.1 
Carter and Jeukendrup (4) VO2 @ 100 and 150 watts 2.3 – 19.8* 
Crouter et al. (7) VO2 (submax. to max. levels) 4.7 – 14.2* 
Vilhena de Mendonça and 
Pereira (25) 
VO2max 8.6 
Jensen and Johansen (10) VO2max 1.9 
Katch et al. (11) VO2max 3.7-7.3 
Kuipers (12) VO2max 7.6 
Kuipers et al. (13) VO2max 7.9 
Rosdahl et al. (22) VO2max 1.7-3.4 
Wright et al. (26) VO2max 5.1-6.8 
Submaximal Exercise 
The mean values of VO2 and VCO2 (Figure 2), RER and VE (Figure 3), and the HR and 
O2pulse (Figure 4) collected during the 25%, 50%, and 75% levels of exercise were very stable from 
one session to the next.  As was the case for the maximal exercise data, the RER value exhibited the 
greatest amount of variation, with the intra-class correlation coefficients ranging from 0.11 to 0.31 
(Table 3).  The other variables examined indicated strong to very strong reliability between test 
sessions.  The CV values were within the 3%-7% range.  For RER, even though the ICC values 
indicated poor reliability, the CV ranged from 3.2% to 4.4%, a value that is very consistent with 
published data (Table 5). 
Table 5.  A summary of previous studies and their reported CV for RER.  The higher values 
reported are from evaluations of metabolic gas analysis systems that produce less consistent results. 
Citation Measure CV (%) 
Carter and Jeukendrup (4) RER @ 100 and 150 W 3.2-11.7* 
Vilhena de Mendonça and Pereira (25) RER max 5.9 
Goedecke et al. (8) RER @ 25, 50, 75% W max 1.4–2.0 
Rosdahl et al. (22) RER max 1.2-8.0* 
FEO2 and FECO2 
FEO2 values obtained from the PM and the PPFS ranged between 15.7 and 19.0% and were 
comparable (Figure 5).  The coefficient of determination (R2) of the relationship was >0.99 and the 
joint test of slope and intercept indicated no significant differences between 1.0 (95% conf. (0.92, 
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1.05)) and 0 (95% conf. (-0.81, +1.28)), respectively.  These statistical results indicate that for practical 
purposes, the devices could be expected to yield similar results (19).  Although the coefficient of 
determination also was quite high for the PPFS vs. PM relationship for FECO2 (R2 > 0.99), and the 
joint test of slope and intercept did not reject the hypothesized respective values of 1.0 and 0 (P = 
0.11), the 95% confidence limits for the slope (0.84, 1.00) suggested a probable reduced gain.  In this 
respect, the FECO2 data from the two devices did not match as well as the FEO2 values.  We examined 
the expired gas fraction in the present study because the PPFS measurements of FECO2 and VCO2 
were lower than the values from the PM in a previous study (17).  This trend was verified in our 
current study.  Therefore, it is possible that a calibration factor (equation) could be applied to the 
FECO2 values obtained by the PPFS and adjusted values incorporated into the metabolic calculations 
performed by the PPFS.  The ADAM software can do this with relative ease.  Using the data from our 
study, we obtained the PPFs response model PPFS-FECO2= 0.921*PM- FECO2 + 0.390, based on the 
assumption that the PM is a “gold standard” device.  The PM has been well validated for 
measurements of metabolic gas exchange at levels ranging from rest to peak exercise (2, 6, 7).  We 
have been using the PM device in our laboratory since 2004 for routine pre- and post-flight testing of 
astronauts, and we performed an unpublished evaluation of the PM analyzer vs. mass spectrometer 
measurements of expired respiratory gases that showed excellent agreement of data.  This PPFS 
response model could then be inverted to give the calibration equation: 
FECO2(calibrated) = (PPFS-FECO2 – 0.390)/0.921. 
Other Issues 
Devices such as the PM, which assume normal room air concentrations of inspired air, cannot 
be used on the ISS because, under nominal circumstances ISS cabin O2 concentrations are allowed to 
range from 19.2% to 23.5% at a pressure of 760 mmHg.  CO2 concentrations are typically in the 
0.25%-0.5% range on the ISS, although 0.7% is the highest permissible level for long-term exposure 
and up to 1.0% is permissible for exposure of less than 24 hours (NASA ISS Generic Flight Rules, 
Volume B, 2011; online at http://mod.jsc.nasa.gov/da8/rules/vol_b/rules.htm). 
Room or cabin air gas composition also affects PPFS output; however the PPFS software is 
designed to incorporate and adjust for environmental measurements before each data analysis.  During 
the current investigation, we used the same computational approach in our ground study as used in ISS 
operations.  The PPFS acquires samples of both inspired and expired gases on a breath-by-breath basis 
(although mixing bag values are used for obtaining mixed-expired gas samples).  Prior to testing, while 
the subject is in the resting phase and is connected to and breathing through the respiratory valves, 
samples of inspired concentrations (end inspiratory tidal) levels of O2 and CO2 are measured.  These 
values are used in the subsequent metabolic calculations.  The mean (±SD) “room air” value for O2 
measured by the PPFS in our investigation was 21.04 ± 0.13 %, which is not significantly different 
from the “normal” atmospheric value of 20.93%.  In contrast, the “room air” concentration of CO2 
measured by the PPFS was 0.16 ± 0.03 %, which is about five times normal atmospheric values 
(0.03%).  Although we are unsure of the cause, this is not surprising given that PPFS FECO2 values 
were higher than PM values at the lower exercise intensities.  However, the elevated level of CO2 in 
the testing room does add a source of error into the metabolic calculations.  Elevated room air CO2 
within the range we observed has a negligible effect on VO2 calculations (<0.5 % difference in VO2).  
However, when 0.16% instead of 0.03% is used as the room air value for inspired CO2, VCO2 values at 
all levels of exercise are lower by about 3% (assuming that the measured FECO2 value is correct).  
Whereas this does not explain the instability of the RER measurements in this study, the ∼3% 
reduction in VCO2 is partially responsible for the RER value not reaching 1.1 (a value consistent with 
true maximal effort) during some of our tests.  Judging from their appearance, subjective comments, 
and reported ratings of perceived exertion, we believe all our subjects gave maximal efforts during the 
tests. 
 18 
In a previous PPFS validation study (17), we reported a 6.1% higher mean VO2max when it 
was measured using the PM than when using the PPFS (PM: 3.32 ± 0.87 L/min, PPFS: 3.11 ± 0.75 
L/min).  We hypothesized that the difference in VO2max was likely due to inspiratory and expiratory 
flow restrictions imposed by the PPFS cardiac output valve.  Although it was not an objective of our 
current study, thus not reported in the results, the mean (± SD) VO2max value measured by the PM in 
our initial test was 2.91 ± 0.70 L/min vs. 3.00 ± 0.66 L/min measured by the PPFS in the first of the 
three reliability trials.  A paired t-test shows that this is not a significant difference (P=0.12).  Granted, 
the testing protocols used to measure VO2max at maximum exertion were different for the two devices 
in the current study, but nevertheless the result indicates that the PM and PPFS yield similar values for 
VO2max.  It is possible that simple random interactions between our subjects and the devices 
contributed to the higher PM values in our first evaluation. 
Throughout this report oxygen consumption measured at maximal exertion during the peak 
cycle tests has been referred to as “VO2max.”  This is technically not the correct terminology for our 
measurement because we performed no specific verification of a plateau in oxygen consumption with 
increasing work rates, which is the criterion for “true” VO2max (23).  However, not all individuals can 
attain this plateau and previous comparisons have reported no statistical difference between VO2max 
and peak oxygen consumption, which is the correct description for the variable reported here.  Further, 
because the terms VO2max and peak oxygen consumption have been used interchangeably in various 
spaceflight and bed rest publications, we have chosen to use only “VO2max” in the description of test 
results contained in this report. 
CONCLUSIONS 
In practically all respects the PPFS yielded highly reliable metabolic gas analysis data.  RER 
was the only output variable that exhibited poor to fair intra-subject agreement; however, RER has 
been reported to be a physiologic response that exhibits poor ICC, and the CV of RER measured in this 
study for matches those published by others.  The elevated levels of CO2 in the testing room and lower 
concentrations of CO2 measured during exercise should have been be more thoroughly controlled 
and/or accounted for, as they might have resulted in slightly lower VCO2 values calculated by the 
PPFS.  However, these observations regarding CO2 measures seem to be stable, and all data collected 
using the PPFS would contain a similar bias.  To clarify this, we recommend collecting more data to 
better calibrate the PPFS CO2 values. 
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APPENDIX A – ACRONYM LIST 
BP Blood Pressure 
CO2 Carbon Dioxide 
CV% Coefficients of Variation 
FECO2 Fractions of Expired Carbon Dioxide 
FEO2 Fractions of Expired Oxygen 
HRP Human Research Program 
ICC Intraclass Correlation Coefficients 
ISS International Space Station 
NASA National Aeronautics and Space Administration 
O2 Oxygen 
PM ParvoMedics TrueOne 
PFS Pulmonary Function System 
PPFS Portable Pulmonary Function System 
RER Respiratory Exchange Ratio 
RERmax Maximal Respiratory Exchange Ratio 
VE Expired Ventilation 
VCO2 Carbon Dioxide Production 
VCO2max Maximal Carbon Dioxide Production 
VO2 Oxygen Consumption 
VO2max Maximal Oxygen Consumption 
W Watt 
WS SD Within-Subject Standard Deviations 
 
